Singlera Genomics partners with Pure Medical to bring early cancer detection to Europe
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
Singlera and Pure Medical will team up with local universities, hospital networks, and national healthcare systems across Western Europe for research studies
The primary goal of the collaboration is joint research into trending and next-generation molecules
NGD Infection Prevention was formed to scale the delivery of sequence-based transmission detection
The collaboration aims to combine synthetic biology with cutting-edge detection technology to create a first-of-its-kind oral pill embedded with tumor-targeting sensors
Tolebrutinib had been provisionally approved in the United Arab Emirates in July 2025 for nrSPMS to slow disability accumulation independent of relapse activity
Wayrilz represents a new approach to ITP by targeting the disease at its root through multi-immune modulation
The multicenter study will enroll 75 patients across 16 sites in Germany, Bulgaria, Poland, and Spain
Masitinib targets mast cells, which play a critical role in severe forms of SCD and its complications, including vaso-occlusive crises, acute chest syndrome, and pain
Study published in laboratory investigation, the official journal of the United States and Canadian Academy of Pathology
Subscribe To Our Newsletter & Stay Updated